REAL-WORLD EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS

被引：0
|
作者：
Astigarraga Urkia, U. [1 ]
Lopez I Gomez, M. [2 ]
Pineiro, I. [1 ]
Ibarrola Paino, L. [1 ]
Sada Urmeneta, G. [1 ]
Mendizabal, J. [1 ]
Del Val Del Amo, N. [1 ]
Garrido Courel, L. [1 ]
Paniagua Zudaire, I. [1 ]
Horcada, L. [1 ]
Gutierrez, R. [1 ]
Fito-Manteca, C. [1 ]
机构：
[1] Hosp Univ Navarra, Rheumatol, Pamplona, Spain
[2] Hosp Univ Arava, Rheumatol, Vitoria, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Real-world evidence; Psoriatic arthritis; Spondyloarthritis;
D O I：
10.1136/annrheumdis-2023-eular.6012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0973
引用
收藏
页码：1705 / 1706
页数：2
相关论文
共 50 条
  • [21] SECUKINUMAB EFFECTIVENESS AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY IN THE REAL-WORLD SETTING
    Gaffney, Karl
    Gullick, Nicola
    Kiltz, Uta
    Sfikakis, Petros
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Perella, Chiara
    Pournara, Effie
    Schulz, Barbara
    Veit, Justyna
    RHEUMATOLOGY, 2021, 60 : 99 - +
  • [22] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [23] Efficacy and safety of secukinumab in Chinese patients with psoriatic arthritis: Evidence from a real-world study
    Zhang Xiaohui
    Chen Yuan
    Geng Yan
    Deng Xuerong
    Zhang Zhuoli
    中华医学杂志英文版, 2024, 137 (21)
  • [24] SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: DRUG SURVIVAL IN REAL-WORLD SETTING AND RESPONSE FACTORS
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Martin, Maria
    Valero, Marta
    Bachiller-Corral, Javier
    Joven-Ibanez, Beatriz
    Perez Gomez, Ana
    Campos Esteban, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 887 - 887
  • [25] DRUG SURVIVAL OF SECUKINUMAB FOR PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING
    Valero, Marta
    Joven-Ibanez, Beatriz
    Martin, Maria
    Campos Esteban, Jose
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Perez Gomez, Ana
    Bachiller-Corral, Javier
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1862 - 1862
  • [26] Effectiveness and safety of generic tofacitinib in spondyloarthritis: A real-world retrospective analysis from India
    Phatak, Sanat
    Khenat, Aditya
    Malandkar, Mansi
    Amin, Sanjiv
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (03) : 487 - 492
  • [27] Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
    Moskal, Mateusz
    Krawiec, Piotr
    Zareba, Wojciech
    Swierczek, Izabella
    Ratusznik, Jakub
    Raputa, Wiktor
    Zielinski, Maciej
    Batko, Krzysztof
    Huk, Mikita
    Batko, Bogdan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [28] Real-world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety
    Asawanonda, Pravit
    Pattamadilok, Bensachee
    Chularojanamontri, Leena
    Chuamanochan, Mati
    Choonhakarn, Charoen
    Chakkavittumrong, Panlop
    Sangob, Naruemon
    Rajatanavin, Natta
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [29] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [30] Real-world effectiveness and safety of alirocumab
    Mondelo Garcia, C.
    Garcia Queiruga, M.
    Balea Filgueiras, J.
    Fernandez Bargiela, N.
    Gimenez Arufe, V.
    Fernandez Oliveira, C.
    Martin Herranz, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 377 - 378
12345